--- title: "全球人类肝脏模型市场 2025-2030:3D 生物打印和肝病研究驱动的增长" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/229945688.md" description: "全球人类肝脏模型市场预计将在 2024 年从 13.4 亿美元增长，2025 年至 2030 年的年均增长率为 14.04%。这一增长受到肝病发病率上升、3D 生物打印技术进步以及对肝癌治疗需求增加的推动。报告强调，由于像非酒精性脂肪肝病（NAFLD）等慢性肝脏疾病影响着全球 25% 的人口，迫切需要准确的人类肝脏模型。器官打印技术的重大进展正在改变医疗保健，解决器官短缺问题，并改善患者护理" datetime: "2025-02-27T15:57:25.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/229945688.md) - [en](https://longbridge.com/en/news/229945688.md) - [zh-HK](https://longbridge.com/zh-HK/news/229945688.md) --- # 全球人类肝脏模型市场 2025-2030:3D 生物打印和肝病研究驱动的增长 Dublin, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The "Human Liver Model Market Size, Share & Trends Analysis Report By Product (2D Models, 3D Models), By Application (ADME Studies, Toxicology Testing), By End Use, By Region, And Segment Forecasts, 2025 - 2030" report has been added to **ResearchAndMarkets.com's** offering. The global human liver model market size was valued at USD 1.34 billion in 2024 and is projected to grow at a CAGR of 14.04% from 2025 to 2030. The industry is driven by the increasing prevalence of liver diseases, advancements in organ printing technologies, and increased demand for therapeutic drugs for liver cancer, which is expected to propel its growth. According to the Health Resources & Services Administration, in 2023, in the U.S., 106,800 individuals are waiting for organ transplants. The healthcare landscape is evolving, and advancements in 3D printing technology are set to transform healthcare by addressing organ shortages and improving patient care globally. The prevalence of liver diseases is on the rise globally, leading to a growing demand for advanced research tools, including human liver models. Chronic liver conditions such as non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, viral hepatitis, and liver cancer are becoming increasingly common due to factors such as unhealthy diets, sedentary lifestyles, alcohol consumption, and viral infections. For instance, NAFLD emerged as the most prevalent chronic liver disorder in Western countries, affecting approximately 25% of the global population. This significant rise in the prevalence of liver diseases has driven the urgent need for more accurate and efficient human liver models to support research and drug development efforts. Organ 3D printing technologies have advanced significantly recently, particularly in developing human liver models. These advancements have revolutionized regenerative medicine and drug testing by providing more accurate and personalized models for research purposes. For instance, in February 2023, researchers at the University of California San Diego made significant progress in addressing challenging issues in bio-printing 3D-engineered tissues, achieving high cell density, viability, and precise fabrication resolution. **Global Human Liver Model Market Report Segmentation** This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the global human liver model market report on the basis of product, application, end-use, and region. **Key Topics Covered:** **Chapter 1. Methodology and Scope** **Chapter 2. Executive Summary **2.1. Market Outlook 2.2. Segment Snapshot 2.3. Competitive Landscape Snapshot **Chapter 3. Human Liver Model Market Variables, Trends & Scope **3.1. Market Lineage Outlook 3.2. Market Dynamics 3.2.1. Market driver analysis 3.2.1.1. Increasing prevalence of liver diseases 3.2.1.2. Advancements in organ printing technologies 3.2.1.3. Increased demand for therapeutic drugs for liver cancer 3.2.2. Market restraint analysis 3.2.2.1. High costs and complexity associated with maintaining human liver models 3.3. Human Liver Model Market Analysis Tools 3.3.1. Industry Analysis - Porter's 3.3.2. PESTEL Analysis 3.3.3. COVID-19 Impact Analysis **Chapter 4. Human Liver Model Market: Product Estimates & Trend Analysis **4.1. Product Segment Dashboard 4.2. Global Human Liver Model Market Product Movement Analysis, 2024 & 2030 (USD Million) 4.3. Global Human Liver Model Market Size and Trend Analysis, by Product, 2018 to 2030 (USD Million) 4.4. 2D Models 4.4.2. Cell Lines 4.4.3. Primary Cells 4.5. 3D Models 4.5.1. 3D models market estimates and forecasts 2018 to 2030 (USD Million) 4.5.2. Liver on Chip 4.5.3. Organoids 4.5.4. Spheroids 4.5.5. Others **Chapter 5. Human Liver Model Market: Application Estimates & Trend Analysis **5.1. Application Segment Dashboard 5.2. Global Human Liver Model Market Application Movement Analysis, 2024 & 2030 (USD Million) 5.3. Global Human Liver Model Market Size and Trend Analysis, by Application, 2018 to 2030 (USD Million) 5.4. ADME Studies 5.5. Toxicology Testing 5.6. Disease Modelling 5.7. Others **Chapter 6. Human Liver Model Market: End-use Estimates & Trend Analysis **6.1. End-use Segment Dashboard 6.2. Global Human Liver Model Market End-use Movement Analysis, 2024 & 2030 (USD Million) 6.3. Global Human Liver Model Market Size and Trend Analysis, by End-use, 2018 to 2030 (USD Million) 6.4. Academic & Research Institutes 6.5. Pharmaceutical & Bioproduct Companies 6.6. Contract Research Organizations **Chapter 7. Human Liver Model Market: Regional Estimates & Trend Analysis **7.1. Human Liver Model Market: Regional Estimates & Trend Analysis by Product, Application, and End-use 7.2. Regional Market Dashboard 7.3. Regional Market Share Analysis, 2024 & 2030 **Chapter 8. Competitive Landscape **8.1. Company/Competition Categorization 8.2. Strategy Mapping 8.3. Company Market Position Analysis, 2024 8.4. Company Profiles For more information about this report visit https://www.researchandmarkets.com/r/s7z7p4 **About ResearchAndMarkets.com** ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. ### 相关股票 - [300049.CN](https://longbridge.com/zh-CN/quote/300049.CN.md) ## 相关资讯与研究 - [润建股份海外收入增近四成 年内股价上涨 141% 拟赴港上市](https://longbridge.com/zh-CN/news/286886812.md) - [从聊天框到流水线：AI 开始渗透义乌的小店与工厂](https://longbridge.com/zh-CN/news/287106057.md) - [强瑞技术控股股东拟减持不超 1.9335% 股份](https://longbridge.com/zh-CN/news/286905322.md) - [侨银股份走慢棋，夏冠明拒绝急功近利](https://longbridge.com/zh-CN/news/287199290.md) - [青岛啤酒股份将于 8 月 10 日派发末期股息每股 2.35 元](https://longbridge.com/zh-CN/news/287223727.md)